More potent HER-2 inhibition: New EGFR/HER family-directed strategies

Date 05 March 2016
Event ESMO Symposium on Signalling Pathways in Cancer 2016
Session Targeting the EGFR/HER family in breast and gastric cancers
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer
Personalised Medicine
Translational Research
Presenter Javier Cortés
Authors J. Cortés
  • Medical Oncology, Vall d'Hebron Institute of oncology, 08035 - Barcelona/ES